Cosmo N.V. (COPN.SW)
Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
61.50+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+5.1%
The outlook
Cosmo N.V. currently reads as neutral based on strong buy — 1.0 avg of 5 analysts, below its 50- & 200-day averages, 11% of the way from its 52-week low to high, avg target +98% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Price targetAvg target +98% vs current price
Analyst price target
~12-month · 5 analysts121.95average target+98.3% vs now
Now 61.50
Low 92.12High 162.38
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.06B
52-wk high
129.40
52-wk low
53.40
50-day avg
68.90
200-day avg
85.65
Trailing P/E
—